Phosphatidylinositol-3-kinase (Pi3K) inhibitors
A DrugBank category of 7 drugs. 6 of them are approved.
- ATC classification
What you can answer from here — as of August 31, 2022
Which targets do Phosphatidylinositol-3-kinase (Pi3K) inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account